Get the Stockscreener App
3.269
1.84%
0.059
After Hours:
3.27
0.0010
+0.03%
Evoke Pharma Inc Stock (EVOK) Forecast
The Evoke Pharma Inc (EVOK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.0037, representing a +114.25% increase from the current price of $3.269. The highest analyst price target is $10.88, and the lowest is $3.1278.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVOK Price Target
Average 35.05
(+972.30% Upside)
Is Evoke Pharma Inc (EVOK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 29.74 | Buy |
| STOCH(9,6) | 23.83 | Neutral |
| STOCHRSI(14) | 16.59 | Buy |
| MACD(12,26) | -0.3608 | Sell |
| ADX(14) | 30.44 | Sell |
| William %R | -89.69 | Buy |
| CCI(14) | -58.40 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.6693
Sell
|
3.6639
Sell
|
| MA20 |
4.1291
Sell
|
3.9807
Sell
|
| MA50 |
4.4612
Sell
|
4.3513
Sell
|
| MA100 |
4.671
Sell
|
4.637
Sell
|
| MA200 |
5.0792
Sell
|
5.5225
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, EVOK could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on EVOK, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 29.74 indicates that EVOK is oversold. This indicates that EVOK price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 23.83 indicates that EVOK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.59 indicates that EVOK is oversold. This suggests that EVOK price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.44 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -58.4 indicates that EVOK is still oversold but not to an extreme extent.
Long-term EVOK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evoke Pharma Inc financial reports and earnings history, Evoke Pharma Inc (EVOK) stock could reach $7.6485 by 2030, $3.9904 by 2040 and $11.19 by 2050. See the projected annual prices until 2050 of the Evoke Pharma Inc stock below:
- Evoke Pharma Inc (EVOK) is expected to reach an average price of $1.0013 in 2035, with a high prediction of $1.224 and a low estimate of $1.0713. This indicates an $-69.37% rise from the last recorded price of $3.269.
- Evoke Pharma Inc (EVOK) stock is projected to chart a bullish course in 2040, with an average price target of $3.9574, representing an $21.06% surge from its current level. The forecast ranges from a conservative $3.9636 to a sky-high $3.9904.
- Our analysts predict Evoke Pharma Inc (EVOK) to jump 175.85% by 2045, soaring from $9.0565 to an average price of $9.0175, potentially reaching $8.814. While $9.0565 is the low estimate, the potential upside is significant.
- Evoke Pharma Inc (EVOK) stock is expected to climb by 2050, reaching an average of $11.19, a $242.34% jump from its current level. However, a wide range of estimates exists, with high and low targets of $11.19 and $10.73, respectively, highlighting the market's uncertainty.
Evoke Pharma Inc Stock (EVOK) Year by Year Forecast
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2025
Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $35.05 in 2025, with a high prediction of $66.98 and a low estimate of $3.1278. This indicates an +972.30% rise from the last recorded price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $7.676 | $3.1278 | $10.88 | +134.81% |
| May, 2025 | $9.6311 | $5.72 | $11.31 | +194.62% |
| June, 2025 | $11.53 | $8.2164 | $11.89 | +252.67% |
| July, 2025 | $22.21 | $11.91 | $27.61 | +579.38% |
| August, 2025 | $35.75 | $32.67 | $54.03 | +993.47% |
| September, 2025 | $44.48 | $33.85 | $47.46 | +1,261% |
| October, 2025 | $60.08 | $43.43 | $66.98 | +1,738% |
| November, 2025 | $50.70 | $47.19 | $61.31 | +1,451% |
| December, 2025 | $40.38 | $39.66 | $54.49 | +1,135% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2026
The predicted value for Evoke Pharma Inc (EVOK) in 2026 is set at an average of $29.83. Estimates vary from a peak of $52.52 to a trough of $7.1428, indicating an +812.62% surge from the present price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.12 | $28.90 | $41.36 | +851.83% |
| February, 2026 | $29.65 | $26.89 | $33.92 | +807.06% |
| March, 2026 | $28.19 | $24.78 | $38.99 | +762.28% |
| April, 2026 | $35.99 | $25.00 | $52.52 | +1,001% |
| May, 2026 | $22.28 | $21.29 | $37.17 | +581.70% |
| June, 2026 | $18.06 | $15.85 | $22.85 | +452.50% |
| July, 2026 | $8.9415 | $8.7015 | $18.09 | +173.52% |
| August, 2026 | $12.52 | $8.3897 | $13.12 | +282.93% |
| September, 2026 | $10.48 | $9.0383 | $13.38 | +220.54% |
| October, 2026 | $8.4146 | $8.0102 | $11.01 | +157.41% |
| November, 2026 | $9.711 | $7.1428 | $14.56 | +197.06% |
| December, 2026 | $11.39 | $8.4392 | $12.59 | +248.47% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evoke Pharma Inc (EVOK) is $35.64, with a high forecast of $71.25 and a low forecast of $0.0266. This indicates an +990.20% increase from the last price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.01 | $9.6396 | $13.26 | +236.73% |
| February, 2027 | $6.6029 | $6.1841 | $12.28 | +101.99% |
| March, 2027 | $3.2529 | $2.1764 | $6.8202 | -0.49% |
| April, 2027 | $2.3041 | $2.178 | $3.9274 | -29.52% |
| May, 2027 | $2.2984 | $1.889 | $3.4731 | -29.69% |
| June, 2027 | $3.608 | $2.5373 | $4.6254 | +10.37% |
| July, 2027 | $2.454 | $1.9498 | $3.8217 | -24.93% |
| August, 2027 | $1.5363 | $0.9086 | $2.5489 | -53.00% |
| September, 2027 | $0.3893 | $0.2813 | $71.25 | -88.09% |
| October, 2027 | $0.0571 | $0.6552 | $0.567 | -98.25% |
| November, 2027 | $0.2134 | $0.0266 | $0.3653 | -93.47% |
| December, 2027 | $0.1861 | $0.0343 | $0.7398 | -94.31% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2028
In 2028, Evoke Pharma Inc (EVOK) is projected to reach an average price of $1.8594, with a high projection of $3.6783 and a low estimate of $0.0405. This indicates an -43.12% fall from the last price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2898 | $0.3039 | $0.1598 | -91.13% |
| February, 2028 | $0.8935 | $0.4957 | $0.4635 | -72.67% |
| March, 2028 | $0.913 | $0.8453 | $0.853 | -72.07% |
| April, 2028 | $1.0467 | $0.9908 | $0.9567 | -67.98% |
| May, 2028 | $0.1937 | $0.5364 | $0.9726 | -94.07% |
| June, 2028 | $1.6401 | $0.2519 | $1.664 | -49.83% |
| July, 2028 | $0.9364 | $0.7164 | $3.6783 | -71.35% |
| August, 2028 | $1.4869 | $0.5405 | $1.5869 | -54.52% |
| September, 2028 | $0.00319 | $0.185 | $1.6059 | -99.90% |
| October, 2028 | $0.2995 | $0.0405 | $0.4794 | -90.84% |
| November, 2028 | $0.145 | $0.0586 | $0.5035 | -95.56% |
| December, 2028 | $0.0537 | $0.1837 | $0.2081 | -98.36% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2029
The 2029 price forecast for Evoke Pharma Inc Stock (EVOK) is $3.0967 on average, with a high prediction of $6.186 and a low estimate of $0.00735. This represents an -5.27% decrease from the previous price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0367 | $0.00735 | $0.1426 | -98.88% |
| February, 2029 | $0.4069 | $0.0292 | $0.217 | -87.55% |
| March, 2029 | $0.2306 | $0.2188 | $0.1947 | -92.95% |
| April, 2029 | $0.0241 | $0.0483 | $0.2076 | -99.26% |
| May, 2029 | $0.0762 | $0.0556 | $0.1562 | -97.67% |
| June, 2029 | $0.3025 | $0.0303 | $0.3403 | -90.75% |
| July, 2029 | $0.0692 | $0.0461 | $0.3966 | -97.88% |
| August, 2029 | $0.1807 | $0.043 | $0.193 | -94.47% |
| September, 2029 | $0.1233 | $0.1444 | $0.1166 | -96.23% |
| October, 2029 | $0.0419 | $0.063 | $0.092 | -98.72% |
| November, 2029 | $0.0791 | $0.0353 | $0.0792 | -97.58% |
| December, 2029 | $7.0524 | $0.0351 | $6.186 | +115.74% |
Evoke Pharma Inc Stock (EVOK) Price Forecast for 2030
Evoke Pharma Inc Stock (EVOK) is expected to reach an average price of $4.3711 in 2030, with a high forecast of $8.3902 and a low forecast of $0.3519. This signifies an +33.71% surge from the last price of $3.269.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.2639 | $7.1921 | $7.6485 | +122.21% |
| February, 2030 | $3.8997 | $6.3513 | $6.7622 | +19.29% |
| March, 2030 | $3.6182 | $3.6374 | $2.5586 | +10.68% |
| April, 2030 | $2.3659 | $3.6847 | $3.0742 | -27.63% |
| May, 2030 | $3.265 | $2.7965 | $3.0838 | -0.12% |
| June, 2030 | $3.5176 | $4.0924 | $3.4687 | +7.60% |
| July, 2030 | $3.2285 | $0.3715 | $6.4685 | -1.24% |
| August, 2030 | $4.8612 | $2.8212 | $7.2848 | +48.71% |
| September, 2030 | $4.6627 | $3.4951 | $6.7094 | +42.63% |
| October, 2030 | $4.9347 | $3.2066 | $8.3902 | +50.96% |
| November, 2030 | $1.3742 | $0.4889 | $6.3029 | -57.96% |
| December, 2030 | $0.0799 | $0.3519 | $2.153 | -97.56% |
0.19%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):